DAYA HAMBAT VIRGIN COCONUT OIL TERHADAP PERTUMBUHAN JAMUR CANDIDA ALBICANS YANG DIISOLASI DARI SAMPEL SWAB VAGINA

Authors

  • Burhannuddin Burhannuddin Poltekkes Kemenkes Denpasar
  • I W. Karta
  • B. Tresnanda
  • I G. N. D. Putra
  • I P. A. Darmada
  • , I. I D. A. Pradnyadhita
  • I W. B. A. Gunawan
  • I M. B. Ariawan

DOI:

https://doi.org/10.23887/jstundiksha.v6i2.10535

Abstract

Prevalensi kandidiasis meningkat seiring dengan meningkatnya populasi penderita imunokompromais. Resistensi C. albicans terhadap berbagai agen anti fungi juga dilaporkan mengalami peningkatan. Pengembangan obat yang berbasis bahan alam dan dapat bertindak sebagai anti fungi terhadap C. albicans perlu terus dilakukan. Penelitian ini bertujuan untuk mengetahui daya hambat VCO terhadap pertumbuhan C. albicans yang diisolasi dari swab vagina. Isolasi dilakukan dengan metode kultur, identifikasi mikroskopis, dan uji biokimia. Uji daya hambat VCO terhadap C. albicans isolat vagina dilakukan dengan metode difusi cakram.  Jamur C. albicans berhasil diisolasi dari swab vagina dengan ciri-ciri koloni yeast, membentuk blastospora, pseudohifa, klamidopora, dan germ tube. Hasil uji difusi cakram menunjukkan VCO mampu menghambat pertumbuhan jamur C. albicans. VCO pada konsentrasi 90 %  memiliki daya hambat tertinggi, dengan nilai zona hambat minimum  24,0 mm, lebih besar dibandingkan VCO pada konsentrasi 75 % (20 mm), 50 % (9,7 mm),  25 % (1,9 mm), dan kontrol negatif (0,0 mm). Namun nilai Zona Hambat tersebut lebih rendah secara bermakna dengan kontrol positif (Ketokenazol 2 %) (p< 0,05). VCO mengandung berbagai zat aktif yang dapat bekerja sebagai anti fungi, seperti asam laurat, asam kaprilat, dan asam kaprat. Zat monolaurin dan monokaprin yang dihasilkan VCO dapat merusak struktur membran sel jamur. Berdasarkan hasil tersebut maka VCO berpotensi digunakan sebagai obat alternatif untuk infeksi C. albicans

 

Kata kunci: Daya hambat, VCO, Candida albicans, Swab vagina

 

References

Arendrup, M.C. 2010. Epidemiology of invasive candidiasis. Curr Opin Crit Care .16. 445–452.

Bergsson, G., Arnfinnsson, J. & Arnfinnsson, H. 2001. In Vitro Killing of Candida albicans by Fatty Acids and Monoglycerides In Vitro Killing of Candida albicans by Fatty Acids and Monoglycerides. Antimicrobial agents and chemotherapy. 45(11). 3209–3212.

Cernicka, J. & Subik, J. 2006. Resistance mechanisms in fluconazole-resistant Candida albicans isolates from vaginal candidiasis. International journal of antimicrobial agents. 27(5). 403–408.

Chomchalow, N. 2011. Health and Economic Benefits of Coconut Oil Production Development in Thailand. AU J.T. 14(3). 181–187.

Dalle, F. et al. 2010. Cellular interactions of Candida albicans with human oral epithelial cells and enterocytes. Cellular Microbiology. 12(2). 248–271.

Van Delden, C. & Iglewski, B.H. 1998. Cell-to-cell signaling and Pseudomonas aeruginosa infections. Emerging Infectious Diseases. 4(4).551–560.

Deorukhkar, S.C. 2016. Changing Trends in Epidemiology of Candidiasis and Role of Non-Albicans. iMedPub Journal. 1(1). 3–4.

Guerrero, H.T. et al. 2016. Distribution of Candida Species and Molecular Typing of C . albicans Isolates in a Mexico City Tertiary Care Hospital from 2011 to 2013. Open Journal of Medical Microbiology. 6 .66–79.

Jasim, S.T., Flayyih, M.T. & Hassan, A.A. 2016. Isolation and identification of Candida spp . From different clinical specimens and study the virulence. World journal of pharmacy and pharmaceutical sciences. 5(7).121–137.

Kett, D.H. et al. 2011. Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study. Critical care medicine. 39(4).665–670.

Khan, M.S.A. et al. 2010. Virulence and Pathogenicity of Fungal Pathogens with Special Reference to Candida albicans. In Combating Fungal Infections. Aligarh: Springer-Verlag Berlin Heidelberg 2010. 21–45.

Lass-Flörl, C. 2009. The changing face of epidemiology of invasive fungal disease in Europe. Mycoses. 52(3).197–205.

Lieberman, S., Enig, M.G. & Preuss, H.G. 2006. A review of monolaurin and lauric acid: natural virucidal and bactericidal agents. Alternative & complementary alternatives.310–314.

Liu, Y. & Filler, S.G. 2011. Candida albicans Als3, a multifunctional adhesin and invasin. Eukaryotic Cell. 10(2). 168–173.

Maidin, N.Q.H. & Ahmad, N. 2015. Protective and antidiabetic effects of virgin coconut oil (VCO) on blood glucose concentrations in alloxan induced diabetic rats. International Journal of Pharmacy and Pharmaceutical Sciences. 7(10). 57–60.

Marina, A. M., Cheman, Y.B., Nazimah, S.A.H. & Amin, I. 2009. Chemical Properties of Virgin Coconut Oil. Journal of the American Oil Chemists’ Society. 86(4). 301–307.

Marina, A.M., Che Man, Y.B. & Amin, I. 2009. Virgin coconut oil: emerging functional food oil. Trends in Food Science and Technology. 20(10).481–487.

Miranda, L.N. et al. 2009. Candida colonisation as a source for candidaemia. Journal of Hospital Infection. 72(1). 9–16.

Ogbolu, D.O. et al. 2007. In vitro antimicrobial properties of coconut oil on Candida species in Ibadan, Nigeria. J Med Food. 10(2). 384–387.

Pfaller, M.A. et al. 2011. Candida bloodstream infections: Comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009. Antimicrobial Agents and Chemotherapy. 55(2) .561–566.

Pfaller, M.A. et al. 2007. Multicenter comparison of the VITEK 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, flucytosine, and voriconazole against Candida spp. Journal of Clinical Microbiology. 45(11). 3522–3528.

Pfaller, M.A. & Diekema, D.J. 2002. Role of Sentinel Surveillance of Candidemia: Trends in Species Distribution and Antifungal Susceptibility. J. Clin. Microbiol. 40(10). 3551–3557.

Salehei, Z., Seifi, Z. & Mahmoudabadi, A.Z. 2012. Sensitivity of vaginal isolates of Candida to eight antifungal drugs isolated from Ahvaz, Iran. Jundishapur Journal of Microbiology. 5(4).574–577.

Salehi, M. et al. 2016. The Epidemiology of Candida Species Isolated From Urinary Tract Infections. Arch Clin Infect Dis. 11(4).

Sanguinetti, M. & Posteraro, B. 2015. Antifungal drug resistance among Candida species: mechanisms and clinical impact . Mycoses. 58. 2–13.

Sardi, J.C.O. et al. 2013. Candida species: Current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. Journal of Medical Microbiology. 62(1).10–24.

Silalahi, J., Permata, Y.M. & Putra, E.D.L. 2014. Antibacterial Activity of Hydrolyzed Virgin Coconut Oil. Asian Journal of Pharmaceutical and Clinical Research. 7(2). 90–94.

Skrivanova, E. et al. 2006. Susceptibility of Escherichia coli, Salmonella sp. and Clostridium perfringens to organic acids and monolaurin. Veterinarni Medicina. 51(3). 81–88.

Tangwatcharin, P., et al. 2012. Activity of Virgin Coconut Oil , Lauric Acid or Monolaurin in Combination With Lactic. Southeast Asian J Trop Med Public Health. 43(4). 969–985.

Thormar, H. et al. 1999. Hydrogels containing monocaprin have potent microbicidal activities against sexually transmitted viruses and bacteria in vitro. Sexually transmitted infections, 75(3).181–185.

Vautier, S. et al. 2015. Candida albicans colonization and dissemination from the murine gastrointestinal tract: The influence of morphology and Th17 immunity. Cellular Microbiology. 17(4). 445–450.

Vediyappan, G. et al. 2013. Gymnemic acids inhibit hyphal growth and virulence in Candida albicans. PloS one. 8(9).

Zordan, R. & Cormack, B. 2012. Adhesins in Opportunistic Fungal Pathogens. Washington, DC: ASM Press.

Downloads

Published

2017-11-10

Issue

Section

Articles